evotec news - Search News

Evotec, Novo Nordisk

Evotec and Novo Nordisk in technology development partnership

German drug and development company Evotec has entered into a technology development partnership with Novo Nordisk to support clinical and commercial manufacturing of stem cell-based therapies, the company said on Thursday.

Benzinga on MSN · 22h

Novo Nordisk And Evotec Collaborate On Stem Cell-Based Therapy Development

Evotec SE (NASDAQ:EVO) entered a technology development partnership with Novo Nordisk A/S (NYSE:NVO) in cell therapy. Evotec and Novo Nordisk have significant expertise and a strategic focus on supporting stem cell-based therapies.

BioSpace · 23h

Novo, Evotec Ink Stem Cell Partnership as Drugmaker Looks to Expand Pipeline

While the companies did not reveal the financial details of the deal, Novo Nordisk will provide funding for two Evotec sites in Germany and Italy to support the development of next-generation cell therapies.

The Pharma Letter · 1d

Evotec and Novo Nordisk team up on cell therapies

Evotec has entered a partnership with Novo Nordisk to develop next-generation off-the-shelf cell therapy technologies. Novo Nordisk will fund R&D at Evotec’s sites in Germany and Italy, with an option for exclusive rights to use the results in a specific therapeutic area.

Business Insider · 1d

EQS-News: Evotec and Novo Nordisk enter into technology development partnership to support next-generation cell therapies

Hamburg, Germany, 26 September 2024: Evotec SE (Frankfurt Stock Exchange: EVT, SDAX/TecDAX, ISIN: DE0005664809; NASDAQ: EVO) announced today that Evotec has entered a technology development partnership with Novo Nordisk in cell therapy.

emjreviews.com · 23h

Novo Nordisk expands stem cell research arm with Evotec

Evotec has joined forces with Novo Nordisk to advance the clinical and commercial manufacturing of stem cell-based therapies.

Investing · 1d

Evotec shares surge after technology partnership with Novo Nordisk

Shares of Evotec (ETR: EVTG)rose on Thursday after the company said it has entered a technology development partnership with Novo Nordisk (NYSE: NVO) in cell ther

YAHOO!Finance · 1d

Evotec and Novo Nordisk Enter into Technology Development Partnership to Support Next-Generation Cell Therapies

Novo Nordisk will provide funding for technology development activities at Evotec to support clinical and commercial manufacturing of stem cell-based therapies HAMBURG, GERMANY / ACCESSWIRE / September 26,

Warburg Research Keeps Their Buy Rating on Evotec (0IRF)

In a report released today, Christian Ehmann from Warburg Research maintained a Buy rating on Evotec (0IRF – Research Report), with a ...

Pharmaceutical Technology3d

Evotec gets grant for inhibitors of epithelial sodium channel for treating diseases

Discover Evotec SE's groundbreaking patent for ENaC-inhibiting compounds, offering innovative treatments for respiratory, skin, and ocular diseases. Explore their potential!

Investing17h

Evotec SE ADR (EVO)

Investing.com - Evotec SE ADR reported on Wednesday third quarter earnings that missed analysts' forecasts and revenue that fell short of expectations. Evotec SE ADR announced ...